149 related articles for article (PubMed ID: 27663271)
1. Structural Insights into the Inhibitory Mechanism of an Antibody against B7-H6, a Stress-Induced Cellular Ligand for the Natural Killer Cell Receptor NKp30.
Xu X; Narni-Mancinelli E; Cantoni C; Li Y; Guia S; Gauthier L; Chen Q; Moretta A; Vély F; Eisenstein E; Rangarajan S; Vivier E; Mariuzza RA
J Mol Biol; 2016 Nov; 428(22):4457-4466. PubMed ID: 27663271
[TBL] [Abstract][Full Text] [Related]
2. Expression, crystallization and X-ray diffraction analysis of a complex between B7-H6, a tumor cell ligand for the natural cytotoxicity receptor NKp30, and an inhibitory antibody.
Xu X; Li Y; Gauthier L; Chen Q; Vivier E; Mariuzza RA
Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):697-701. PubMed ID: 26057798
[TBL] [Abstract][Full Text] [Related]
3. Secreted Ligands of the NK Cell Receptor NKp30: B7-H6 Is in Contrast to BAG6 Only Marginally Released via Extracellular Vesicles.
Ponath V; Hoffmann N; Bergmann L; Mäder C; Alashkar Alhamwe B; Preußer C; Pogge von Strandmann E
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671836
[TBL] [Abstract][Full Text] [Related]
4. Mimicking an induced self phenotype by coating lymphomas with the NKp30 ligand B7-H6 promotes NK cell cytotoxicity.
Kellner C; Maurer T; Hallack D; Repp R; van de Winkel JG; Parren PW; Valerius T; Humpe A; Gramatzki M; Peipp M
J Immunol; 2012 Nov; 189(10):5037-46. PubMed ID: 23066150
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients.
Semeraro M; Rusakiewicz S; Minard-Colin V; Delahaye NF; Enot D; Vély F; Marabelle A; Papoular B; Piperoglou C; Ponzoni M; Perri P; Tchirkov A; Matta J; Lapierre V; Shekarian T; Valsesia-Wittmann S; Commo F; Prada N; Poirier-Colame V; Bressac B; Cotteret S; Brugieres L; Farace F; Chaput N; Kroemer G; Valteau-Couanet D; Zitvogel L
Sci Transl Med; 2015 Apr; 7(283):283ra55. PubMed ID: 25877893
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells.
Fiegler N; Textor S; Arnold A; Rölle A; Oehme I; Breuhahn K; Moldenhauer G; Witzens-Harig M; Cerwenka A
Blood; 2013 Aug; 122(5):684-93. PubMed ID: 23801635
[TBL] [Abstract][Full Text] [Related]
7. B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors.
Kaifu T; Escalière B; Gastinel LN; Vivier E; Baratin M
Cell Mol Life Sci; 2011 Nov; 68(21):3531-9. PubMed ID: 21877119
[TBL] [Abstract][Full Text] [Related]
8. NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure.
Zou Y; Bao J; Pan X; Lu Y; Liao S; Wang X; Wang G; Lin D
PLoS One; 2015; 10(8):e0134568. PubMed ID: 26241657
[TBL] [Abstract][Full Text] [Related]
9. Affinity Maturation of B7-H6 Translates into Enhanced NK Cell-Mediated Tumor Cell Lysis and Improved Proinflammatory Cytokine Release of Bispecific Immunoligands via NKp30 Engagement.
Pekar L; Klausz K; Busch M; Valldorf B; Kolmar H; Wesch D; Oberg HH; Krohn S; Boje AS; Gehlert CL; Toleikis L; Krah S; Gupta T; Rabinovich B; Zielonka S; Peipp M
J Immunol; 2021 Jan; 206(1):225-236. PubMed ID: 33268483
[TBL] [Abstract][Full Text] [Related]
10. Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6.
Li Y; Wang Q; Mariuzza RA
J Exp Med; 2011 Apr; 208(4):703-14. PubMed ID: 21422170
[TBL] [Abstract][Full Text] [Related]
11. Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30.
Schlecker E; Fiegler N; Arnold A; Altevogt P; Rose-John S; Moldenhauer G; Sucker A; Paschen A; von Strandmann EP; Textor S; Cerwenka A
Cancer Res; 2014 Jul; 74(13):3429-40. PubMed ID: 24780758
[TBL] [Abstract][Full Text] [Related]
12. Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions.
Matta J; Baratin M; Chiche L; Forel JM; Cognet C; Thomas G; Farnarier C; Piperoglou C; Papazian L; Chaussabel D; Ugolini S; Vély F; Vivier E
Blood; 2013 Jul; 122(3):394-404. PubMed ID: 23687088
[TBL] [Abstract][Full Text] [Related]
13. Tumor Therapeutics Work as Stress Inducers to Enhance Tumor Sensitivity to Natural Killer (NK) Cell Cytolysis by Up-regulating NKp30 Ligand B7-H6.
Cao G; Wang J; Zheng X; Wei H; Tian Z; Sun R
J Biol Chem; 2015 Dec; 290(50):29964-73. PubMed ID: 26472927
[TBL] [Abstract][Full Text] [Related]
14. HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity.
Peipp M; Derer S; Lohse S; Staudinger M; Klausz K; Valerius T; Gramatzki M; Kellner C
Oncotarget; 2015 Oct; 6(31):32075-88. PubMed ID: 26392331
[TBL] [Abstract][Full Text] [Related]
15. B7-H6, an immunoligand for the natural killer cell activating receptor NKp30, reveals inhibitory effects on cell proliferation and migration, but not apoptosis, in cervical cancer derived-cell lines.
Banu N; Riera-Leal A; Haramati J; Ortiz-Lazareno PC; Panikar SS; Bastidas-Ramirez BE; Gutierrez-Silerio GY; Solorzano-Ibarra F; Tellez-Bañuelos MC; Gutierrez-Franco J; Bueno-Topete MR; Pereira-Suarez AL; Del Toro-Arreola S
BMC Cancer; 2020 Nov; 20(1):1083. PubMed ID: 33172426
[TBL] [Abstract][Full Text] [Related]
16. [Research Advances of A New Co-stimulatory Molecule-B7 Homolog 6--Review].
Wu FF; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):295-8. PubMed ID: 26913440
[TBL] [Abstract][Full Text] [Related]
17. Affinity Maturation of the Natural Ligand (B7-H6) for Natural Cytotoxicity Receptor NKp30 by Yeast Surface Display.
Zielonka S; Krah S; Arras P; Lipinski B; Zimmermann J; Boje AS; Klausz K; Peipp M; Pekar L
Methods Mol Biol; 2023; 2681():231-248. PubMed ID: 37405651
[TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus escapes immune recognition by NK cells through the downregulation of B7-H6 by the viral genes US18 and US20.
Charpak-Amikam Y; Kubsch T; Seidel E; Oiknine-Djian E; Cavaletto N; Yamin R; Schmiedel D; Wolf D; Gribaudo G; Messerle M; Cicin-Sain L; Mandelboim O
Sci Rep; 2017 Aug; 7(1):8661. PubMed ID: 28819195
[TBL] [Abstract][Full Text] [Related]
19. An NKp30-based chimeric antigen receptor promotes T cell effector functions and antitumor efficacy in vivo.
Zhang T; Wu MR; Sentman CL
J Immunol; 2012 Sep; 189(5):2290-9. PubMed ID: 22851709
[TBL] [Abstract][Full Text] [Related]
20. Homo-oligomerization of the activating natural killer cell receptor NKp30 ectodomain increases its binding affinity for cellular ligands.
Herrmann J; Berberich H; Hartmann J; Beyer S; Davies K; Koch J
J Biol Chem; 2014 Jan; 289(2):765-77. PubMed ID: 24275655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
